The medication-assisted treatment (MAT) market finds applications primarily in the field of addiction treatment. MAT combines behavioral therapy with medications such as methadone, buprenorphine, and naltrexone to manage substance use disorders, especially opioids and alcohol. The dominating segment within the MAT market is opioid addiction treatment. With the opioid crisis gripping many nations, MAT's effectiveness in reducing cravings and withdrawal symptoms has led to its widespread adoption. MAT programs have become a cornerstone in addressing the opioid epidemic, offering hope for recovery and improved quality of life.
According to Data Bridge Market Research, the Global Medication-Assisted (MAT) Treatment Market will grow at a CAGR of 9.4% during the forecast period of 2022 to 2029.
“Reimbursement for medication-assisted treatment (MAT) boost the market’s growth”
The driver behind the use of reimbursement for medication-assisted treatment (MAT) lies in its effectiveness in combating addiction. As governments and healthcare systems recognize the urgency of addressing substance use disorders, they incentivize MAT adoption by offering reimbursement programs. These programs lower the financial burden on patients, making treatment more accessible. Consequently, healthcare providers and facilities are increasingly embracing MAT, thereby bolstering the MAT market's growth as a vital component in the fight against addiction.
What restraints the growth of the global medication-assisted (MAT) treatment market?
“Shortage of skilled professionals restraints the market’s growth”
A significant restraint in the medication-assisted treatment (MAT) market is the shortage of skilled professionals, including physicians, counselors, and nurses, trained in MAT administration. The specialized knowledge and training required for MAT can limit its widespread adoption. The shortage of qualified personnel can hinder the expansion of MAT programs, limiting access to treatment for individuals with substance use disorders.
Segmentation: Global Medication-Assisted Treatment (MAT) Market
The global medication-assisted (MAT) treatment market is segmented on the basis of eight segments: type, products, drug type, dosage form, route of administration, population type, end user, and distribution channel.
- On the basis of type, the global medication-assisted (MAT) treatment market is segmented into medication, and therapy.
- On the basis of products, the global medication-assisted (MAT) treatment market is segmented into buprenorphine and naloxone, naltrexone, buprenorphine, methadone, naloxone, disulfiram, and acamprosate.
- On the basis of drug type, the global medication-assisted (MAT) treatment market is segmented into generics, and branded.
- 根據劑型，全球藥物輔助 (MAT) 治療市場分為速釋和緩釋。
- 根據給藥途徑，全球藥物輔助 (MAT) 治療市場分為口服、腸外和其他。
- 根據人口類型，全球藥物輔助（MAT）治療市場分為成年人和青少年。
- 根據最終用戶，全球藥物輔助 (MAT) 治療市場分為復健診所、醫院、專科中心、家庭護理和其他。
- 根據分銷管道，全球藥物輔助（MAT）治療市場分為醫院藥房、直接招標、零售藥房、網路藥房等。
區域洞察：北美預計將主導全球藥物輔助治療 (MAT) 市場
由於物質使用疾患日益普遍，北美可望維持市場主導地位。正在進行的臨床試驗和製藥公司的積極參與有助於該地區在藥物輔助治療 (MAT) 市場中佔據領先地位。解決成癮相關挑戰的緊迫性，加上研究和製藥計劃，使北美成為推動 MAT 應用及其相關治療的關鍵驅動力
要了解有關該研究的更多信息，請訪問： https://www.databridgemarketresearch.com/reports/global-medication-assisted-treatment-mat-market
近期發展
- 2021 年 4 月，Adamis Pharmaceuticals Corporation 與 USWM 合作推出了高劑量 ZIMHI 注射納洛酮產品，旨在減少阿片類藥物過量致死人數。預計此次產品的推出將推動產品部門收入的成長，從而促進整體市場的擴張。此外，ZIMHI 還以較低的價格提供，以支持急救人員和社區健康組織應對阿片類藥物相關緊急情況的努力。
全球藥物輔助治療（MAT）市場的主要參與者包括：
- Indivior PLC（英國）
- Orexo US Inc.（Orexo AB 的子公司）（瑞典）
- 美國復健中心（美國）
- 阿爾克姆斯（愛爾蘭）
- 太陽製藥工業有限公司（印度）
- 普渡製藥（美國）
- 泰姬製藥有限公司（印度）
- 蘭內特（美國）
- Hikma Pharmaceuticals PLC（約旦）
- 輝瑞公司（美國）
- 巔峰治療中心（美國）
- 美國成癮中心（美國）
- Adamis Pharmaceuticals Corporation（美國）
- Glenmark Pharmaceutical Inc.（美國）
- Viatris Inc.（美國）
- Mallinckrodt（英國）
- Alvogen（美國）
- Accord Healthcare（英國）
- VistaPharm, Inc.（美國）
- 梯瓦製藥工業股份有限公司（以色列）
- 雷迪博士實驗室有限公司（印度）
- Amneal Pharmaceuticals LLC（美國）
- 泰坦製藥公司（美國）
Above are the key players covered in the report, to know about more and exhaustive list of global medication-assisted (MAT) treatment market companies contact, https://www.databridgemarketresearch.com/contact
Research Methodology: Global Medication-Assisted Treatment (MAT) Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
